More doses of AstraZeneca vaccines for Mandaue health workers arrive

By: Mary Rose Sagarino - CDN Digital | May 12,2021 - 05:12 PM
vaccines

One of the frontliners of Mandaue City gets a vaccine shot at a vaccination center in Mandaue City in this March 2021 photo. | CDN Digital file photo

MANDAUE CITY, Cebu—The Mandaue City Government received 700 more doses of AstraZeneca (AZ) vaccines from the Department of Health in Central Visayas (DOH-7) on Tuesday, May 11, 2021.

Subangdaku Barangay Captain Ernie Manatad, the chairman of the city’s COVID-19 vaccine board, said the new batch of AZ vaccines are the second doses of the medical workers who received the first dose last March.

The city will start to give the second jab on Friday, May 14, still at the Mandaue City Cultural and Sports Complex.

Mandaue City has more than 2,000 medical workers aside from those working in private hospitals.

Out of the 2,000 medical workers, only 1,400 were vaccinated. Out of the 1,400, some received AZ vaccines while others got the SinoVac vaccines.

Manatad said there were still 30 doses left out of the 600 doses of Sinovac vaccines intended for medical workers’ second dose.

It can be recalled that the city received 1,600 doses of China’s SinoVac last April 30. 1,000  were given as the first dose to more senior citizens while the 600 doses were intended for the medical workers’ second dose.

Manatad said the 30 doses of Sinovac will be given this Friday together with the AstraZeneca vaccines.

Read more:

More Mandaue City frontliners get Sinovac jabs

/bmjo

 

Read Next

Disclaimer: The comments uploaded on this site do not necessarily represent or reflect the views of management and owner of Cebudailynews. We reserve the right to exclude comments that we deem to be inconsistent with our editorial standards.

TAGS: AstraZeneca, AZ vaccines, COVID-19 vaccines, Department of Health in Central Visayas, DOH-7, Sinovac, Subangdaku Barangay Captain Ernie Manatad

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.